Cargando…
Improvement of eosinophilic chronic rhinosinusitis after infection with severe acute respiratory syndrome corona virus 2 during dupilumab therapy: A case report
Eosinophilic chronic rhinosinusitis (ECRS) is an intractable type 2 inflammatory disease of the paranasal sinuses that persists even after endoscopic sinus surgery (ESS) and systemic corticosteroid therapy. Dupilumab, a monoclonal antibody against the shared receptor components of interleukin (IL)-4...
Autores principales: | Koike-Ieki, Mariko, Kagoya, Ryoji, Toma-Hirano, Makiko, Sasajima, Yuko, Ito, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932033/ https://www.ncbi.nlm.nih.gov/pubmed/36819831 http://dx.doi.org/10.3389/falgy.2023.1053777 |
Ejemplares similares
-
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
por: Fujieda, Shigeharu, et al.
Publicado: (2020) -
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
por: D'Amato, Maria, et al.
Publicado: (2022) -
Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report
por: van der Lans, Rik J. L., et al.
Publicado: (2021) -
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023) -
Immunological status of the olfactory bulb in a murine model of Toll-like receptor 3-mediated upper respiratory tract inflammation
por: Kagoya, Ryoji, et al.
Publicado: (2022)